Patient demonstrations, ongoing clinical trials and heavy investment signal that BCIs could be commercialised by 2030.

The rise of agentic artificial intelligence (AI) is liable to have multiple use cases for healthcare in patient-facing areas ...

Conformal has completed a Series D extension financing round, securing $32m to support its clinical trial of the CLAAS ...

The SEMR JV between Interventional Systems and HICREN has obtained approval for the Intelligent SpinePecker spinal surgical ...

HeartFlow’s $364m initial public offering (IPO) signals market validation for the use artificial intelligence (AI) in a ...

SetPoint Medical has secured $140m in private financing to accelerate the commercialisation of its SetPoint System, a ...